TWO · Healthcare

Taiwan Advance Bio-Pharmaceutical Inc. (4186)

Biotechnology

Taiwan Advance Bio-Pharmaceutical Inc. (4186) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 4186

P/E ratio

18.00

Taiwan Advance Bio-Pharmaceutical Inc. (4186) — FAQ

What is 4186's P/E ratio?

The price-to-earnings (P/E) ratio for Taiwan Advance Bio-Pharmaceutical Inc. (4186) is 18.00 (data as of 2026-03-23).

Does Taiwan Advance Bio-Pharmaceutical Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Taiwan Advance Bio-Pharmaceutical Inc. (4186). Check the MyAverix Finance app for the latest dividend data.

What sector is Taiwan Advance Bio-Pharmaceutical Inc. in?

Taiwan Advance Bio-Pharmaceutical Inc. (4186) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 4186 listed on?

4186 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)